(Q30807024)

26 June 2017

1 reference

title

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data (English)

1 reference

26 June 2017

0 references

Gianluigi Tanda

1

0 references

author name string

Steven R Goldberg

series ordinal

2

1 reference

26 June 2017

24 June 2003

1 reference

26 June 2017

20

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

26 June 2017

169

1 reference

26 June 2017

115-134

1 reference

26 June 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-003-1485-z

26 June 2017

0 references

cites work

Neuropsychological performance in long-term cannabis users

1 reference

12 December 2020

Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats.

1 reference

12 December 2020

Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A

1 reference

12 December 2020

Incentive-sensitization and addiction

1 reference

12 December 2020

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

12 December 2020

Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.

1 reference

12 December 2020

Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment

1 reference

12 December 2020

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

1 reference

12 December 2020

Marijuana withdrawal among adults seeking treatment for marijuana dependence

1 reference

12 December 2020

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

12 December 2020

Mesolimbic dopaminergic decline after cannabinoid withdrawal

1 reference

12 December 2020

Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination

1 reference

12 December 2020

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

12 December 2020

Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens

1 reference

12 December 2020

Evaluation of cannabimimetic effects of structural analogs of anandamide in rats

1 reference

12 December 2020

Pharmacology of marijuana

1 reference

12 December 2020

THC does not affect striatal dopamine release: Microdialysis in freely moving rats

1 reference

12 December 2020

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

1 reference

12 December 2020

Identification of the endogenous cannabinoid system through integrative pharmacological approaches

1 reference

12 December 2020

Endogenous cannabinoid signaling

1 reference

12 December 2020

Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol

1 reference

12 December 2020

Factors influencing marijuana self-administration by humans.

1 reference

12 December 2020

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

1 reference

12 December 2020

Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system.

1 reference

12 December 2020

Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons.

1 reference

12 December 2020

Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens.

1 reference

12 December 2020

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

1 reference

12 December 2020

Cannabinoid receptors and reward in the rat: a conditioned place preference study.

1 reference

12 December 2020

Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry

1 reference

12 December 2020

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

1 reference

12 December 2020

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

1 reference

12 December 2020

Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

1 reference

12 December 2020

Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice

1 reference

12 December 2020

Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine.

1 reference

12 December 2020

Conditioned place preference: what does it add to our preclinical understanding of drug reward?

1 reference

12 December 2020

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

1 reference

12 December 2020

Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study

1 reference

12 December 2020

Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism.

1 reference

12 December 2020

Tolerance to marijuana: heart rate and subjective "high".

1 reference

12 December 2020

Drugs of abuse: anatomy, pharmacology and function of reward pathways

1 reference

12 December 2020

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

12 December 2020

Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system

1 reference

12 December 2020

The endocannabinoid system as a target for therapeutic drugs.

1 reference

12 December 2020

Endocannabinoids and related fatty acid derivatives in pain modulation

1 reference

12 December 2020

Marked decrease of extraneuronal dopamine after alcohol withdrawal in rats: Reversal by MK-801

1 reference

12 December 2020

A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing.

1 reference

12 December 2020

Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats

1 reference

12 December 2020

Drug addiction, dysregulation of reward, and allostasis

1 reference

12 December 2020

Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.

1 reference

12 December 2020

Intravenous self-administration of drugs in rats

1 reference

12 December 2020

An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.

1 reference

12 December 2020

Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys.

1 reference

12 December 2020

Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient

1 reference

12 December 2020

A review of the published literature into cannabis withdrawal symptoms in human users

1 reference

12 December 2020

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

1 reference

12 December 2020

Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice.

1 reference

12 December 2020

Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.

1 reference

12 December 2020

Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence.

1 reference

12 December 2020

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

1 reference

12 December 2020

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

1 reference

12 December 2020

Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators

1 reference

12 December 2020

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

12 December 2020

Pharmacology of cannabinoid receptor ligands.

1 reference

12 December 2020

Cannabinoid transmission and reward-related events.

1 reference

12 December 2020

Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats

1 reference

12 December 2020

Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice

1 reference

12 December 2020

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

1 reference

12 December 2020

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

1 reference

12 December 2020

A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys

1 reference

12 December 2020

Determination and characterization of a cannabinoid receptor in rat brain

1 reference

12 December 2020

Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.

1 reference

12 December 2020

Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.

1 reference

12 December 2020

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

1 reference

12 December 2020

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

12 December 2020

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

1 reference

12 December 2020

Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.

1 reference

12 December 2020

Discovery and characterization of endogenous cannabinoids

1 reference

12 December 2020

(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide

1 reference

12 December 2020

Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys

1 reference

12 December 2020

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

12 December 2020

Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey

1 reference

12 December 2020

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

1 reference

12 December 2020

An evaluation of the history of a marijuana withdrawal syndrome in a large population.

1 reference

12 December 2020

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

12 December 2020

Anatomy of CNS opioid receptors

1 reference

12 December 2020

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

1 reference

12 December 2020

Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions

1 reference

12 December 2020

Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders.

1 reference

12 December 2020

Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.

1 reference

12 December 2020

The effect of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats

1 reference

12 December 2020

Comparison of discriminative and reinforcing effects of ketamine and related compounds in the rhesus monkey.

1 reference

12 December 2020

Study of cannabinoid dependence in animals

1 reference

12 December 2020

Rapid tolerance to Delta(9)-tetrahydrocannabinol and cross-tolerance between ethanol and Delta(9)-tetrahydrocannabinol in mice

1 reference

12 December 2020

Self-administration of Δ9-tetrahydrocannabinol by rats

1 reference

12 December 2020

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

12 December 2020

Cannabinoid transmission and pain perception

1 reference

12 December 2020

Behavioral sensitization to WIN55212.2 in rats pretreated with heroin.

1 reference

12 December 2020

Drug dependence: stress and dysregulation of brain reward pathways

1 reference

12 December 2020

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

1 reference

12 December 2020

Acquisition of drug self-administration: environmental and pharmacological interventions

1 reference

12 December 2020

Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study

1 reference

12 December 2020

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

1 reference

12 December 2020

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

12 December 2020

The role of benzodiazepine receptors in the discriminative stimulus properties of delta-9-tetrahydrocannabinol.

1 reference

12 December 2020

The residual cognitive effects of heavy marijuana use in college students.

1 reference

12 December 2020

Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats

1 reference

12 December 2020

Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.

1 reference

12 December 2020

Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms.

1 reference

12 December 2020

Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study

1 reference

12 December 2020

Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats

1 reference

12 December 2020

Discriminative stimulus effects of phencyclidine: pharmacologically specific interactions with delta 9- and delta 8-tetrahydrocannabinol.

1 reference

12 December 2020

Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

1 reference

12 December 2020

The pharmacologic effects of daily marijuana smoking in humans

1 reference

12 December 2020

Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine.

1 reference

12 December 2020

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice.

1 reference

12 December 2020

Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.

1 reference

12 December 2020

Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics

1 reference

12 December 2020

Modulation of rat brain cannabinoid receptors after chronic morphine treatment

1 reference

12 December 2020

Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization.

1 reference

12 December 2020

Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat.

1 reference

12 December 2020

Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)

1 reference

12 December 2020

Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice.

1 reference

12 December 2020

Anandamide, an endogenous cannabinoid, has a very low physical dependence potential

1 reference

12 December 2020

Effects of body weight levels on Cannabis self-injection

1 reference

12 December 2020

Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis.

1 reference

12 December 2020

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

1 reference

12 December 2020

Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats

1 reference

12 December 2020

Cannabis and endogenous cannabinoid systems.

1 reference

12 December 2020

Discriminative stimulus effects of anandamide in rats

1 reference

12 December 2020

Drug abuse: hedonic homeostatic dysregulation

1 reference

12 December 2020

The effects of cannabinoids on the brain

1 reference

12 December 2020

The role of reward pathways in the development of drug dependence

1 reference

12 December 2020

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

1 reference

12 December 2020

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

12 December 2020

Cannabinoid addiction: behavioral models and neural correlates.

1 reference

12 December 2020

Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain

1 reference

12 December 2020

Relationship between minimum reinforcing doses and injection speed in cocaine and pentobarbital self-administration in crab-eating monkeys.

1 reference

12 December 2020

The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

1 reference

12 December 2020

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide

1 reference

12 December 2020

Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain

1 reference

12 December 2020

Clinical effects and plasma levels of ?9-Tetrahydrocannabinol (?9-THC) in heavy and light users of cannabis

1 reference

12 December 2020

Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.

1 reference

12 December 2020

Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

1 reference

12 December 2020

Tolerance to the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol

1 reference

12 December 2020

Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

1 reference

12 December 2020

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

1 reference

12 December 2020

The central basis of motivation: intracranial self-stimulation studies

1 reference

12 December 2020

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice

1 reference

12 December 2020

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

1 reference

12 December 2020

Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.

1 reference

12 December 2020

Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.

1 reference

12 December 2020

Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence

1 reference

12 December 2020

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

12 December 2020

Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys.

1 reference

12 December 2020

Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze

1 reference

12 December 2020

The psychoactive ingredient of marijuana induces behavioural sensitization.

1 reference

12 December 2020

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

1 reference

12 December 2020

Cannabis: discrimination of "internal bliss"?

1 reference

12 December 2020

Cannabinergic ligands

1 reference

12 December 2020

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication.

1 reference

12 December 2020

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

12 December 2020

delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat.

1 reference

12 December 2020

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Brain stimulation reward and dopamine terminal fields. I. Caudate-putamen, nucleus accumbens and amygdala.

1 reference

12 December 2020

Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration

1 reference

12 December 2020

Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.

1 reference

12 December 2020

Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters

1 reference

12 December 2020

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens

1 reference

12 December 2020

Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

1 reference

12 December 2020

Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring.

1 reference

12 December 2020

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

12 December 2020

The reinforcing properties of diazepam under several conditions in the rhesus monkey.

1 reference

12 December 2020

Precipitated and spontaneous withdrawal in rats tolerant to anandamide

1 reference

12 December 2020

Behavioral sensitization to heroin by cannabinoid pretreatment in the rat.

1 reference

12 December 2020

Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys

1 reference

12 December 2020

Neurobiology of opiate abuse

1 reference

12 December 2020

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

1 reference

12 December 2020

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

1 reference

12 December 2020

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

12 December 2020

Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain

1 reference

12 December 2020

(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.

1 reference

12 December 2020

Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats

1 reference

12 December 2020

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

1 reference

12 December 2020

Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys

1 reference

12 December 2020

Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys

1 reference

12 December 2020

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

1 reference

12 December 2020

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

12 December 2020

Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis

1 reference

12 December 2020

Abstinence symptoms following smoked marijuana in humans.

1 reference

12 December 2020

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

1 reference

12 December 2020

Responses to Oral Δ9-Tetrahydrocannabinol in Frequent and Infrequent Marijuana Users

1 reference

12 December 2020

Addictive Drugs and Brain Stimulation Reward

1 reference

12 December 2020

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

1 reference

12 December 2020

Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice

1 reference

12 December 2020

Marijuana abstinence effects in marijuana smokers maintained in their home environment

1 reference

12 December 2020

Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats

1 reference

12 December 2020

The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes

1 reference

12 December 2020

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

12 December 2020

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

12 December 2020

Preclinical assessment of abuse liability of drugs

1 reference

12 December 2020

delta 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

1 reference

12 December 2020

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

1 reference

12 December 2020

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats.

1 reference

12 December 2020

The partitioning of delta 1-tetrahydrocannabinol into erythrocyte membranes in vivo and its effect on membrane fluidity

1 reference

12 December 2020

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

12 December 2020

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

1 reference

12 December 2020

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

1 reference

12 December 2020

10.1007/S00213-003-1485-Z

Identifiers

DOI

1 reference

PubMed ID

12827346

Dimensions Publication ID

26 June 2017

0 references

1 reference

PubMed ID

12827346